OpenGovernment
Ultra-rare Gene-based Therapy (URGenT) Network | National Institute of Neurological Disorders and Stroke
Grant from THE AMERICAN SOCIETY OF GENE & CELL
The Ultra-rare Gene-based Therapy (URGenT) Network supports the development of gene-based therapies for ultra-rare neurological diseases through two-stage application processes, including preliminary and protocol applications. Potential applicants are strongly encouraged to contact program staff…
- Funder
- THE AMERICAN SOCIETY OF GENE & CELL
- Deadline
- Open until filled or withdrawn
- Status
- Open
- Eligibility
- Academic investigators, industry applicants, private institutions, or nonprofits.
- Official source
- ninds.nih.gov
Open in GrantAuthority. The full listing, application link, requirements, attachments, program contacts and your organization's fit score are available with a free account.